特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
921270

ウェスタンブロッティング市場 - 成長、傾向、予測

Western Blotting Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 110 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
ウェスタンブロッティング市場 - 成長、傾向、予測
出版日: 2020年06月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 110 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ウェスタンブロッティングは、その特異性、低コスト、使いやすさにより、市場で注目を集めています。世界中でのHIVの負担の増加、バイオテクノロジーおよび製薬セクターでの調査活動の拡大、製薬会社およびバイオテクノロジー会社による研究開発投資の増加などの要因が市場を牽引しています。

当レポートでは、ウェスタンブロッティングの世界市場を調査し、市場の概要、タイプ、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概要
  • 成長要因
  • 抑制要因
  • ファイブフォース分析
    • 新規参入の脅威
    • 消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内での競争

第5章 市場セグメンテーション

  • 製品別
    • 機器
    • 消耗品
  • アプリケーション別
    • 生物医学・生化学調査
    • 病気診断
    • その他
  • エンドユーザー別
    • 学界・調査研究機関
    • 診断センター
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • LI-COR Biosciences
    • Bio-Techne Corporation
    • GE Healthcare
    • Merck KGaA
    • PerkinElmer, Inc.
    • Cell Signaling Technology
    • Advansta, Inc.
    • Danaher Corporation (Lumigen, Inc.)

第7章 市場機会および将来動向

目次
Product Code: 67106

The western blotting market is majorly driven by factors such as the rising burden of chronic diseases across the globe, growing research activities in the biotech and pharma sector, and raised R&D investment done by pharmaceutical and biotechnology companies.

Western blotting is a widely known and used test that is used in cell and molecular biology. With the help of this test, one can detect the specific type of protein from the complex mixture of proteins that is extracted from the cell. This test has gained attraction in the market due to its specificity, low cost, and ease of use.

Despite the technique that has been evolved since its inception, there have been several advancements in this technique that occurred in the last decade. Introduction of capillary and microfluidic platforms is one of the advancements which has helped immensely in reducing the time taken for test and decreased the sample requirements along with enabling high-throughput capabilities. Hence, owing to the certain characteristics of the western blot test, the market is believed to witness considerable growth over the forecast period.

Key Market Trends

Disease Diagnostic Segment will be Witnessing a Healthy CAGR Over the Forecast Period

Western blot test is having a wide range of applications in medical diagnostics. For the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy), FIV (Feline Immunodeficiency Virus), HBV (Hepatitis B Virus) infection, Lyme Disease among others.

Generally, this test is used as a confirmatory test for the above-mentioned diseases after the ELISA test is done with a positive result. For Lyme Disease, US FDA has suggested the two-tier protocol using an ELISA test initially and then the specific western blot tets for the confirmation of diagnosis if the results of ELISA are positive.

Previously, western blotting was commonly done to confirm the HIV diagnosis. However, the Centre for Disease Control and Prevention (CDC) in the year has recommended discontinuing the Western blot test for HIV as there are novel techniques that came up in the market for HIV detection. Furthermore, studies have suggested that western blot is a priority test for the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy), and FIV (Feline Immunodeficiency Virus). Hence, owing to the significance of this test in the disease diagnosis, it is indicated that this segment will be witnessing a healthy CAGR over the forecast period.

North America is Expected to Dominates the Western Blotting Market

The global market for western blotting is dominated by the North America region and the United States holds the largest share of this market. The prime factor contributing to the large share in the United States is the developed healthcare system and the presence of key players in the country.

Companies such as Bio-Rad, Thermo Fisher Scientific, etc are having an active presence in the US market and due to the adaptable nature of US population towards the novel products or technologies, companies are able to establish their novel product launches in the United States which is helping the market studied to grow in this region.

Competitive Landscape

The major players are having competition among themselves for the market share and with the rising application of this test and growing pharmaceutical and biotechnology industries, it is believed that few small to mid-sized companies will penetrate the market soon and hold a substantial share in the market. The major market players operating in the western blotting market include Danaher Corporation, Thermofisher Scientific, Biorad laboratories, Perklin Elmer and Merck KgaA among others

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Proteomics Market Across the Globe
    • 4.2.2 Increasing R&D Investment by the Pharma and Biotech Companies
    • 4.2.3 Wide Applications of the Western Blot Test
  • 4.3 Market Restraints
    • 4.3.1 Availability of the Alternatives for Western Blot
    • 4.3.2 Accuracy Issues
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Instruments
      • 5.1.1.1 Gel Electrophoresis Instruments
      • 5.1.1.2 Blotting Systems
      • 5.1.1.3 Imagers
      • 5.1.1.3.1 Chemiluminescent Imagers
      • 5.1.1.3.2 Fluorescent Imagers
      • 5.1.1.3.3 Others
    • 5.1.2 Consumables
      • 5.1.2.1 Reagents
      • 5.1.2.2 Kits
  • 5.2 By Application
    • 5.2.1 Biomedical & Biochemical Research
    • 5.2.2 Disease Diagnostics
    • 5.2.3 Others
  • 5.3 By End-User
    • 5.3.1 Academia and Research Institutes
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bio-Rad Laboratories, Inc.
    • 6.1.2 Thermo Fisher Scientific, Inc.
    • 6.1.3 LI-COR Biosciences
    • 6.1.4 Bio-Techne Corporation
    • 6.1.5 Merck KGaA
    • 6.1.6 PerkinElmer, Inc.
    • 6.1.7 Cell Signaling Technology
    • 6.1.8 Advansta, Inc.
    • 6.1.9 Danaher Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.